Pharmacological Properties of NAI-603, a Well-Tolerated Semisynthetic Derivative of Ramoplanin (vol 58, pg 1922, 2014)ANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52015-10-010OAAI
Pharmacological Properties of NAI-603, a Well-Tolerated Semisynthetic Derivative of RamoplaninANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52014-04-0112OAAI
Efficacy of the New Lantibiotic NAI-107 in Experimental Infections Induced by Multidrug-Resistant Gram-Positive PathogensANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52011-04-01127OAAI
Synthesis and preliminary biological characterization of new semisynthetic derivatives of ramoplaninJOURNAL OF MEDICINAL CHEMISTRYIF6.82007-06-0231PREAI
In vitro antistaphylococcal activity of dalbavancin, a novel glycopeptideJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.62005-03-0153OAAI
Efficacy of dalbavancin against methicillin-resistant Staphylococcus aureus in the rat granuloma pouch infection modelANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52004-04-0155OAAI
In-vitro and in-vivo antibacterial activity of BI 397, a new semi-synthetic glycopeptide antibioticJOURNAL OF ANTIMICROBIAL CHEMOTHERAPYIF3.61999-08-01150PREAI
Potent antifungal effects of a new derivative of partricin A in a murine model of cerebral cryptococcosisANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.51997-03-019OAAI